Publications by authors named "Mindy C Ward"

2 Publications

  • Page 1 of 1

Primary Sclerosing Cholangitis in Crohn's Disease: An Atypical Complication.

Cureus 2021 May 11;13(5):e14964. Epub 2021 May 11.

Florida State University College of Medicine Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, USA.

Crohn's disease (CD) is a type of inflammatory bowel disease (IBD) that affects thousands of Americans, and it is commonly found in individuals aged between 20-30 years. Patients often present with abdominal pain and describe concerns of diarrhea, bloating, and weight loss. In this report, we discuss the case of a 21-year-old man who presented with diarrhea and intermittent hematochezia. He was admitted for a suspected lower gastrointestinal (GI) bleed. An abdominal CT scan demonstrated pancolitis with a mildly distended gallbladder. Subsequent sigmoidoscopy revealed a diagnosis of CD, which was confirmed with a biopsy. Following steroid therapy, the patient reported symptomatic improvement, although his alkaline phosphatase (ALP) levels continued to increase. Magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography (ERCP) revealed biliary strictures, which were suggestive of primary sclerosing cholangitis (PSC). This case highlights the importance of not ruling out CD in patients with PSC and understanding the differential clinical outcomes in patients with PSC with ulcerative colitis (UC) compared to those with CD. These differences include variations in colorectal carcinoma risk and severity of symptoms.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.14964DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192025PMC
May 2021

Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration.

Cureus 2021 May 5;13(5):e14853. Epub 2021 May 5.

Florida State University College of Medicine Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, USA.

A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-year-old Caucasian female who presented to the emergency room with life-threatening thrombocytopenia in the setting of de novo ITP following COVID-19 vaccine administration. Due to the relapsing nature of ITP, it is unclear if the patient has achieved complete remission of the disease.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.14853DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657PMC
May 2021
-->